Haleon Plc (HLNCF)
4.505
+0.04
(+1.01%)
USD |
OTCM |
Jun 10, 16:00
Haleon 1 Year Total Returns (Daily) : -14.92% for June 10, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 10, 2026 | -14.92% |
| June 09, 2026 | -16.24% |
| June 08, 2026 | -22.11% |
| June 05, 2026 | -18.45% |
| June 04, 2026 | -16.50% |
| June 03, 2026 | -19.40% |
| June 02, 2026 | -19.25% |
| June 01, 2026 | -18.20% |
| May 29, 2026 | -17.26% |
| May 28, 2026 | -12.90% |
| May 27, 2026 | -15.26% |
| May 26, 2026 | -15.64% |
| May 22, 2026 | -11.37% |
| May 21, 2026 | -15.20% |
| May 20, 2026 | -18.08% |
| May 19, 2026 | -11.30% |
| May 18, 2026 | -14.10% |
| May 15, 2026 | -15.02% |
| May 14, 2026 | -12.02% |
| May 13, 2026 | -10.92% |
| May 12, 2026 | -13.46% |
| May 11, 2026 | -18.12% |
| May 08, 2026 | -10.12% |
| May 07, 2026 | -12.91% |
| May 06, 2026 | -15.46% |
| Date | Value |
|---|---|
| May 05, 2026 | -14.67% |
| May 04, 2026 | -7.22% |
| May 01, 2026 | -10.85% |
| April 30, 2026 | -3.98% |
| April 29, 2026 | -9.45% |
| April 28, 2026 | -5.09% |
| April 27, 2026 | -3.08% |
| April 24, 2026 | 1.18% |
| April 23, 2026 | -6.07% |
| April 22, 2026 | -5.40% |
| April 21, 2026 | 0.25% |
| April 20, 2026 | -1.32% |
| April 17, 2026 | -4.97% |
| April 16, 2026 | -5.31% |
| April 15, 2026 | -2.04% |
| April 14, 2026 | 0.33% |
| April 13, 2026 | 1.86% |
| April 10, 2026 | 5.48% |
| April 09, 2026 | 12.14% |
| April 08, 2026 | 11.58% |
| April 07, 2026 | 12.30% |
| April 06, 2026 | 7.16% |
| April 02, 2026 | -2.88% |
| April 01, 2026 | 0.42% |
| March 31, 2026 | -2.65% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| AstraZeneca PLC | 23.33% |
| GSK Plc | 28.62% |
| ANI Pharmaceuticals, Inc. | 30.19% |
| Corcept Therapeutics, Inc. | 8.09% |
| Assertio Holdings, Inc. | 136.8% |